Index | All patients | Patients with ALT <2×ULN | Patients with HBeAg negative | |||
---|---|---|---|---|---|---|
AUC (95% CI) | SE | AUC (95% CI) | SE | AUC (95% CI) | SE | |
AA | 0.822 (0.714 to 0.930)* | 0.055 | 0.845 (0.718 to 0.971)* | 0.064 | 0.893 (0.779 to 0.999)* | 0.058 |
AAR | 0.554 (0.411 to 0.697) | 0.073 | 0.566 (0.406 to 0.727) | 0.082 | 0.638 (0.447 to 0.829) | 0.098 |
FIB-4 | 0.691 (0.555 to 0.827)* | 0.070 | 0.643 (0.470 to 0.815) | 0.088 | 0.614 (0.398 to 0.829) | 0.110 |
Forns | 0.687 (0.554 to 0.820)* | 0.068 | 0.690 (0.534 to 0.847)* | 0.080 | 0.636 (0.417 to 0.856) | 0.112 |
APRI | 0.707 (0.579 to 0.834)* | 0.065 | 0.690 (0.546 to 0.835)* | 0.074 | 0.685 (0.484 to 0.886) | 0.103 |
Fibro Q | 0.661 (0.517 to 0.804)* | 0.073 | 0.667 (0.494 to 0.839)* | 0.088 | 0.675 (0.469 to 0.882) | 0.105 |
APGA | 0.758 (0.635 to 0.881)* | 0.063 | 0.748 (0.605 to 0.892)* | 0.073 | 0.695 (0.502 to 0.887) | 0.098 |
PAPAS | 0.630 (0.491 to 0.769) | 0.071 | 0.621 (0.462 to 0.781) | 0.081 | 0.565 (0.344 to 0.786) | 0.113 |
GUCI | 0.729 (0.607 to 0.851)* | 0.062 | 0.719 (0.583 to 0.855)* | 0.069 | 0.714 (0.521 to 0.908)* | 0.099 |
RPR | 0.723 (0.589 to 0.858)* | 0.069 | 0.703 (0.531 to 0.875)* | 0.088 | 0.682 (0.466 to 0.897) | 0.110 |
GP | 0.671 (0.526 to 0.817)* | 0.074 | 0.710 (0.546 to 0.874)* | 0.084 | 0.685 (0.476 to 0.894) | 0.107 |
*p<0.05.
AAR, aspartate aminotransferase to ALT ratio; APGA, α-fetal protein index; APRI, aspartate aminotransferase to platelet ratio index; ALT, alanine aminotransferase; AUC, area under curve; FIB-4, international normalised ratio index; GP, globulin-platelet model; GUCI, Göteborg University Cirrhosis Index; HBeAg, hepatitis B e antigen; PAPAS, aspartate aminotransferase index; RPR, red cell distribution width to platelet ratio; ULN, upper limit of normal.